FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

IMMUNOVANT, INC.: cashflow_investing

One fact, its scope and the complete path back to the official record.

Period: 2020-04-01 – 2021-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/7e33c75e-50da-4df2-a774-0f7cc3566549

Reported value

$-210.000k{"amount": -210000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Entity
IMMUNOVANT, INC.
Metric
cashflow_investing
Period
2020-04-01 – 2021-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001764013-21-000052 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T17:55:26.669332+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001764013/cashflow-investing/2021-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.